Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran

Minerva Gastroenterologica e Dietologica

Volumn 58, Issue 1, 2012, Pages 9-18

  Sayad, B ^a   Anvari, F A ^b   Alavian, S M ^c   Norouzi, M ^b   Hamzelooie, M ^a   Shirvani, M ^a   Pourhoseingholi, A ^d   Khedive, A ^b   Ghamari, S ^b   Judaki, M A ^b   Jazayeri, S M ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amino acids; Genotype; Hepatitis B

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IRAN; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION GENETICS; VIRUS LOAD;

ADULT; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IRAN; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE;

EID: 84860289173     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wallace LA, Carman WF. 1997. Surface gene variation of HBV: Scientific and medical relevance. Viral Hepat. Rev 1997;3:5-16.
2. Honorati MC, Dolzani P, Mariani E, Piacentini A, Lisignoli G, Ferrari C et al. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997;112:2017-27. (Pubitemid 27240789)
3. Mancini BM, Fontaine H, Bréchot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine 2006;24:4482-9. (Pubitemid 43792480)
4. Ducos J, Bianchi-Mondain AM, Pageaux G, Conge AM, Poncet R, Vendrell JP et al. Hepatitis B virus (HBV) specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg). Clin Exp Immunol 1996;103:15-8. (Pubitemid 26029467)
5. Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994;152:3074-87.
6. Tai PC, Banik D, Lin GI, Pai Sh, Pai K, Lin MH et al. Novel and Frequent Mutations of Hepatitis B Virus Coincide with a Major Histocompatibility Complex Class I-Restricted T-Cell Epitope of the Surface Antigen. J Virology 1997;4852-6. (Pubitemid 27204184)
7. Alberti A, Gerlich WH, Heermann KH, Pontisso P. Springer Semin. Immunopathol 1990;2:5-23.
8. Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV. Novel immunoassay for the detection of hepatitis b surface 'escape' mutants and its application in liver transplant recipients. J Med Virol 2001;63:210-6. (Pubitemid 32116475)
9. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the s gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-6. (Pubitemid 24091946)
10. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-7.
11. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepatitis Monthly 2008;8:281-94.
12. Alavianl S M, Fallahian F, Bagheri Lankarani K. The Changing Epidemiology of Viral Hepatitis B in Iran J Gastrointestin Liver Dis 2007;Vol.16 No 4:403-6.
13. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000;3:192-201.
14. Jazayeri M, Basuni AA, Sran N, Gish R, Cooksley G, Locarnini S, Carman WF. HBV core sequence: definition of genotype-specific variabilityand correlation with geographical origin. J Viral Hepatitis 2004;11:488-501. (Pubitemid 39486612)
15. Tamura K, Dudley J, Nei M, Kumar S. Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evolution 2007;24:1596-9. (Pubitemid 47236692)
16. Avello'n A, Echevarria JM. Frequency of Hepatitis B Virus 'a' Determinant Variants in Unselected Spanish Chronic Carriers. J Med Virol 2006;78:24-36. (Pubitemid 41783840)
17. Lada O, Benhamou Y, Poynard T, Thibault V.Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis b virus carriers: influence of "a" determinant variants. J Virol 2006;2968-75. (Pubitemid 43346392)
18. Mesenas SJ, Chow WC, Zhao Y, Lim GK, Oon CJ, Ng HS. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol 2002;17:148-52. (Pubitemid 34415667)
19. Chisari FV. Immunobiology and pathogenesis of viral hepatitis. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica; 1997. p. 405-16.
20. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994;180:933-43. (Pubitemid 24256606)
21. Ehata T, Omata M, Chuang W L, Yokosuka O, Ito Y, Hosoda K et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993;91:1206-13. (Pubitemid 23095300)
22. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Amino acid residues of core region of hepatitis B virus. Asymptomatic carriers versus patients with liver disease. J Gastroenterol Hepatol 1991;6:292-6.
23. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest. 1992;89:332-8.
24. Chen M, Salberg M, Thung SN, Hughes J, Jones J, Milich DR. Modelling the T helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice. Antiviral Res 2001;52:99-111. (Pubitemid 32973684)
25. Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol 2002;68:50-9.
26. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J immunol 1989;143:2650-5. (Pubitemid 19260077)
27. Yamauchi K, Nakamura T, Yonemitsu H, Sekiya H, Katoh J, Obata H. Possible role of preS2 peptides presented by MHC class I antigen in the pathogenesis of chronic hepatitis B. J Hepatol 1993;17:S6-9. (Pubitemid 23114335)
28. Jazayeri SM, Carman WF. Virus escape, CTL or B cell epitopes? Hepatitis Monthly. 2005;5:133-6.
29. Jazayeri SM, Dornan ES, Boner W, Fattovich G, Hadziyannis S, Carman WF. Intracellular Distribution of Hepatitis B Virus Core Protein Expressed In Vitro Depends on the Sequence of the Isolate and the Serologic Pattern. J Infect Dis 2004;189:1634-45. (Pubitemid 38648292)
30. Carman W F, Thursz M, Hadziyannis S, McIntyre G, Colman K, Gioustoz A et al. Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants. J Viral Hepat 1995;2:77-84.
31. Carman WF, Hadziyannis S, Fattovich G, Alberti A, Thomas HC. Core protein evolution after selection of HBV pre core mutants and correlation with disease severity. J Viral Hepat 1994;273-6.
32. Carman W, Thomas H, Domingo E. Viral genetic variation: Hepatitis B virus as a clinical example. Lancet 1993;341:349-53. (Pubitemid 23039709)